BIO-PATH HOLDINGS

bio-path-holdings-logo

Bio-Path is a biotechnology company developing DNAbilizeยฎ, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous infusion. Bio-Pathโ€™s lead product candidate, prexigebersen (BP1001, targeting the Grb2 protein), is in a Phase 2 study for blood cancers and prexigebersen-A, a drug product modification of prexigebersen, is under consideration by the FDA to commence Phase 1 studies in solid tumors.

#SimilarOrganizations #People #Website #More

BIO-PATH HOLDINGS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2007-01-01

Address:
Houston, Texas, United States

Country:
United States

Website Url:
http://www.biopathholdings.com

Total Employee:
1+

Status:
Active

Contact:
(832)971-6616

Email Addresses:
[email protected]

Total Funding:
46.12 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Wordpress Plugins


Similar Organizations

1200-pharma-logo

1200 Pharma

1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

signpath-pharma-logo

Signpath Pharma

Signpath Pharma is a biotechnology company developing therapeutics using curcuminoids extracted from the root of the Curcuma longa plant.

sonnet-biotherapeutics-logo

Sonnet BioTherapeutics

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.


Current Advisors List

gillian-c-ivers-read_image

Gillian C. Ivers-Read Board Member @ Bio-Path Holdings
Board_member

Current Employees Featured

ana-tari-ashizawa_image

Ana Tari Ashizawa
Ana Tari Ashizawa Co-Founder , SVP of Research, Development & Clinical Design @ Bio-Path Holdings
Co-Founder , SVP of Research, Development & Clinical Design
2019-07-01

not_available_image

Douglas P. Morris
Douglas P. Morris Co-Founder & Director of Investor Relations @ Bio-Path Holdings
Co-Founder & Director of Investor Relations

not_available_image

Peter Nielsen
Peter Nielsen Co-Founder ,CEO & CFO @ Bio-Path Holdings
Co-Founder ,CEO & CFO

Founder


ana-tari-ashizawa_image

Ana Tari Ashizawa

not_available_image

Douglas P. Morris

not_available_image

Peter Nielsen

Stock Details


Company's stock symbol is NASDAQ:BPTH

Official Site Inspections

http://www.biopathholdings.com

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Bio-Path Holdings"

Bio-Path Holdings (BPTH) Profile - The Globe and Mail

See the company profile for Bio-Path Holdings (BPTH) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»

Bio-Path Holdings (BPTH) Company Profile & Description

2 days ago Company profile for Bio-Path Holdings, Inc. (BPTH) with a description, list of executives, contact details and other key facts.See details»

Bio-Path Holdings, Inc. (BPTH) Company Profile & Facts - Yahoo โ€ฆ

See the company profile for Bio-Path Holdings, Inc. (BPTH) including business summary, industry/sector information, number of employees, business summary, corporate governance, โ€ฆSee details»

Home - BioPath Holdings

Delivering a Better Path for Cancer Patients. Giving Previously Untreatable Cancer Patients a Fighting Chance We are developing targeted cancer treatments that offer effective therapy without harsh side\u0003effects so that โ€ฆSee details»

Bio-Path Holdings - Crunchbase Company Profile

Bio-Path Holdings is a biotechnology company developing therapeutic products for the liposomal delivery of nucleic acids in cancer patients.See details»

Bio-Path Holdings, Inc. - Executive Bio, Top Executies, and โ€ฆ

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.See details»

Investors - BioPath Holdings

Be a part of our success Bio-Path is developing RNAi nanoparticle drugs for some of the most lethal blood cancers and solid tumors. The companyโ€™s anticancer drug candidates target the โ€ฆSee details»

Bio-Path Holdings - Overview, News & Similar companies

Mar 7, 2024 View Bio-Path Holdings (www.biopathholdings.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as โ€ฆSee details»

Leadership - BioPath Holdings

About Bio-Path Overview Leadership Board of Directors Scientific Advisory Board Partnering Opportunities Technology Pipeline Pipeline Prexigebersen BP1001-A BP1002 BP1003 Patients โ€ฆSee details»

Bio-Path Holdings 2025 Company Profile: Stock Performance

Apr 19, 2017 Information on stock, financials, earnings, subsidiaries, investors, and executives for Bio-Path Holdings. Use the PitchBook Platform to explore the full profile.See details»

Bio Path Holdings Inc, BPTH:QBB profile - FT.com

Jul 18, 2025 Bio Path Holdings Inc (BPTH:QBB) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»

Bio-Path Holdings Company Profile - Office Locations ... - Craft

Oct 29, 2024 Bio-Path Holdings has 5 employees at their 1 location. See insights on Bio-Path Holdings including office locations, competitors, revenue, financials, executives, subsidiaries โ€ฆSee details»

Bio-Path Holdings Company Profile | Management and Employees โ€ฆ

Find contact information for Bio-Path Holdings. Learn about their Research & Development, Business Services market share, competitors, and Bio-Path Holdings's email format.See details»

Bio-Path Holdings - Products, Competitors, Financials, Employees ...

Jun 12, 2025 About Bio-Path Holdings Bio-Path Holdings is an oncology-focused biotechnology company that develops DNA therapeutics for cancer treatment. The company uses its โ€ฆSee details»

About Bio Path Holdings Inc (BPTH) - Investing.com Canada

This page offers an in-depth profile of Bio Path Holdings Inc, including a general overview of the company's business and key management.See details»

Bio-Path Holdings, Inc. Company Profile: Board of Directors, โ€ฆ

Explore Bio-Path Holdings, Inc. company profile, including board of directors, capital structure, raw materials, finished goods, stock DNA, and contact details. Get a complete overview of โ€ฆSee details»

Bio-Path Holdings: Contact Details and Business Profile

Bio-Path Holdings is a Biotechnology, Drug Manufacturing & Research, and Pharmaceuticals company_reader located in Bellaire, Texas with $7000 in revenue and 7 employees. Find top โ€ฆSee details»

Bio-Path Holdings Company Overview, Contact Details

Learn more about Bio-Path Holdings's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»

Bio-Path Holdings, Inc. - Cruelty Free Investing

Bio-Path Holdings, Inc. is a clinical stage biotechnology company, which focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology designed to โ€ฆSee details»

Bio-Path Holdings | LinkedIn

Bio-Path is a biotechnology company developing targeted therapies for acute myeloid leukemia (AML), lymphoma, chronic lymphocytic leukemia, gynecological cancer and other challenging โ€ฆSee details»

linkstock.net © 2022. All rights reserved